Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04181203
Title Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy (CARLHA-2)
Acronym CARLHA-2
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors UNICANCER
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Clinique Claude Bernard NOT_YET_RECRUITING Albi France Details
Institut de Cancérologie de l'Ouest RECRUITING Angers France Details
Institut Bergonié NOT_YET_RECRUITING Bordeau France Details
Centre Georges François LECLERC RECRUITING Dijon France Details
Centre Hospitalier Emile ROUX NOT_YET_RECRUITING Le Puy-en-Velay France Details
Centre Oscar Lambret RECRUITING Lille France Details
Institut de Cancérologie de Montpellier NOT_YET_RECRUITING Montpellier France Details
Centre Antoine Lacassagne RECRUITING Nice France Details
Institut Jean Godinot NOT_YET_RECRUITING Reims France Details
Centre Henri Becquerel NOT_YET_RECRUITING Rouen France Details
Institut de Cancérologie de l'Ouest RECRUITING Saint Herblain France Details
Institut de Cancérologie de la Loire Lucien Neuwirth RECRUITING Saint-Priest-en-Jarez France Details
Institut de Cancérologie Paris Nord NOT_YET_RECRUITING Sarcelles France Details
Centre Paul STRAUSS NOT_YET_RECRUITING Strasbourg France Details
Clinique Pasteur - ONCORAD NOT_YET_RECRUITING Toulouse France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field